目前对肝脏微环境的洞察力和肝细胞癌免疫疗法的进展
Ming Zhao1, Hui Huang1, Feng He1
1Department of Gastroenterology, Clinical Medical College and the First Affiliated Hospital of Chengdu Medical College, Chengdu, Sichuan, China.
Frontiers in immunology
|June 5, 2023
概括
肝细胞癌 (HCC) 治疗受到肝脏独特的免疫微环境的挑战. 本综述探讨了针对瘤微环境的免疫疗法,以获得更好的肝细胞癌结果.
科学领域:
- 肝胆道癌症 肝胆道癌症
- 癌症免疫学 癌症免疫学
- 免疫治疗是一种免疫疗法.
背景情况:
- 肝细胞癌 (HCC) 是一种主要的肝癌,全球死亡率高.
- 肝脏的免疫微环境限制了传统的HCC疗法,如化疗和放射治疗.
- 尽管取得了进展,但一些患者对当前的癌症免疫疗法没有反应.
研究的目的:
- 提供关于HCC.肝脏免疫微环境的见解.
- 总结针对HCC的免疫治疗策略.
- 审查新型HCC免疫疗法的机制和临床应用.
主要方法:
- 关于HCC免疫瘤学进展的文献综述.
- 在肝细胞癌中对肝免疫微环境的分析.
- 目前和新兴的免疫治疗方法对HCC的总结.
主要成果:
- 肝脏的免疫耐受性需要新的治疗策略.
- 免疫疗法通过调节瘤微环境,为HCC治疗提供了一个有希望的途径.
- 目前正在研究针对HCC的各种免疫治疗方案.
结论:
- 向瘤微环境对于下一代HCC免疫治疗至关重要.
- 了解肝脏免疫微环境是提高治疗疗效的关键.
- 对免疫检查点封锁和采用细胞疗法等免疫治疗选择进行进一步的研究是必要的.
更多相关视频
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.9K
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
889
相关概念视频
Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cytotoxic T Cells-mediated Immune Response
1.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.0K
